T 
Protocol 
SJCRH 
2/94;3/94;3/30/94 
USE OF DOUBLE MARKING WITH RETROVIRAL VECTORS TO DETERMINE RATE 
OF RECONSTITUTION OF UNTREATED AND CYTOKINE EXPANDED CD34 + 
SELECTED MARROW CELLS IN PATIENTS UNDERGOING AUTOLOGOUS BONE 
MARROW TRANSPLANTATION 
PRINCIPAL INVESTIGATORS 
Helen E. Heslop, MD, FRACP, FRCPA 
Malcolm K. Brenner, PhD, FRCP 
Robert A Krance MD 
Division of Bone Marrow Transplantation 
CO-INVESTIGATORS 
Richard Heideman MD 
Department of Hematology/Oncology 
John M Cunningham, M.D 
Division of Bone Marrow Transplantation 
Stacye Richardson 
Timothy York 
Bone Marrow Processing/Graft Engineering 
James M. Boyett, Ph.D. 
Deo-Kumar Srivastava, Ph.D. 
Department of Biostatistics 
St. Jude Children’s Research Hospital 
332 N. Lauderdale, P.O. Box 318 
Memphis, Tennessee 38101-0318 
(901) 522 0300 
Ronald Berenson, MD 
CellPro Inc 
Bothell WA 
Stephen G. Marcus, MD 
Genetic Therapy, Inc. 
Gaithersburg, MD 
[488] 
Recombinant DNA Research, Volume 19 
